Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 286 AL 300

Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease

Choi DY, Lee YJ, Hong JT, Lee HJ.

Brain Res Bull. 2012 Feb 10;87(2-3):144-53. doi: 10.1016/j.brainresbull.2011.11.014. Epub 2011 Nov 28.

Characterization of oral disintegrating film containing donepezil for Alzheimer disease

Liew KB, Tan YT, Peh KK.

AAPS PharmSciTech. 2012 Mar;13(1):134-42. doi: 10.1208/s12249-011-9729-4. Epub 2011 Dec 14.

Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier

Banks WA.

Adv Drug Deliv Rev. 2012 May 15;64(7):629-39. doi: 10.1016/j.addr.2011.12.005. Epub 2011 Dec 17.

Vitamin A and Alzheimer's disease

Ono K, Yamada M.

Geriatr Gerontol Int. 2012 Apr;12(2):180-8. doi: 10.1111/j.1447-0594.2011.00786.x. Epub 2011 Dec 23.

A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease

Anand P, Singh B, Singh N.

Bioorg Med Chem. 2012 Feb 1;20(3):1175-80. doi: 10.1016/j.bmc.2011.12.042. Epub 2011 Dec 30.

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

D'Onofrio G, Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Paroni G, Cascavilla L, Seripa D, Pilotto A.

Expert Opin Drug Discov. 2012 Jan;7(1):19-37. doi: 10.1517/17460441.2012.645534. Epub 2011 Dec 14.

Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors

Tayeb HO, Yang HD, Price BH, Tarazi FI.

Pharmacol Ther. 2012 Apr;134(1):8-25. doi: 10.1016/j.pharmthera.2011.12.002. Epub 2011 Dec 16.

Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients--an open-label trial

Kennelly S, Abdullah L, Kenny RA, Mathura V, Luis CA, Mouzon B, Crawford F, Mullan M, Lawlor B.

Int J Geriatr Psychiatry. 2012 Apr;27(4):415-22. doi: 10.1002/gps.2735. Epub 2011 May 10.

Cognitive reserve and its implications for rehabilitation and Alzheimer's disease

Liberati G, Raffone A, Olivetti Belardinelli M.

Cogn Process. 2012 Feb;13(1):1-12. doi: 10.1007/s10339-011-0410-3. Epub 2011 Jun 4.

Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia

Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM.

J Neurol. 2012 Jan;259(1):83-92. doi: 10.1007/s00415-011-6128-4. Epub 2011 Jun 14.

Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT

Kimura N, Kumamoto T, Masuda T, Hanaoka T, Okazaki T, Arakawa R.

J Neuroimaging. 2012 Jul;22(3):299-304. doi: 10.1111/j.1552-6569.2011.00612.x. Epub 2011 Jun 23.

Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study

Likitjaroen Y, Meindl T, Friese U, Wagner M, Buerger K, Hampel H, Teipel SJ.

Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262(4):341-50. doi: 10.1007/s00406-011-0234-2. Epub 2011 Aug 5.

Sexuality in institutionalized elderly persons: a systematic review of argument-based ethics literature

Mahieu L, Gastmans C.

Int Psychogeriatr. 2012 Mar;24(3):346-57. doi: 10.1017/S1041610211001542. Epub 2011 Aug 24.

Alzheimer's therapeutics: translation of preclinical science to clinical drug development

Savonenko AV, Melnikova T, Hiatt A, Li T, Worley PF, Troncoso JC, Wong PC, Price DL.

Neuropsychopharmacology. 2012 Jan;37(1):261-77. doi: 10.1038/npp.2011.211. Epub 2011 Sep 21.

Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease

Mohamed S, Rosenheck R, Lyketsos CG, Kaczynski R, Sultzer DL, Schneider LS.

J Clin Psychiatry. 2012 Jan;73(1):121-8. doi: 10.4088/JCP.10m06574. Epub 2011 Sep 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias